Bill Ericson was selected in the LSIPR 50 2016 publication for his influence on the life sciences industry. Bill Ericson was featured in the investment section, as LSIPR reports.
Name: Bill Ericson
Organisation: Mohr Davidow Ventures
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bill Ericson, Mohr Davidow Ventures, Merck, life science, MDV, molecular diagnostics, patent,
